GRTS - Gritstone Oncology GAAP EPS of -$0.34 beats by $0.07 revenue of $5.47M beats by $2.28M August, 04 2022 05:39 PM Gritstone Oncology Inc. Gritstone Oncology press release ( NASDAQ: GRTS ): Q2 GAAP EPS of -$0.34 beats by $0.07 . Revenue of $5.47M (+92.6% Y/Y) beats by $2.28M . For further details see: Gritstone Oncology GAAP EPS of -$0.34 beats by $0.07, revenue of $5.47M beats by $2.28M